Mullish, B. H., Michael, D. R., Dabcheva, M., Webberley, T. S., Coates, N., John, D. A., Wang, D., Luo, Y., Plummer, S. F., & Marchesi, J. R. (2024). Authors’ reply to letter: He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome. Neurogastroenterology & Motility, 36(8). Portico. https://doi.org/10.1111/nmo.14820

Mullish, B. H., Michael, D. R., Dabcheva, M., Webberley, T. S., Coates, N., John, D. A., Wang, D., Luo, Y., Plummer, S. F., & Marchesi, J. R. (2024). A double‐blind, randomized, placebo‐controlled study assessing the impact of probiotic supplementation on the symptoms of irritable bowel syndrome in females. Neurogastroenterology & Motility, 36(4). Portico. https://doi.org/10.1111/nmo.14751

Brand, D., Pomenti, S., & Katzka, D. A. (2023). Roles of swallowing and belching in different phenotypes of gastroesophageal reflux disease. Neurogastroenterology & Motility, 36(1). Portico. https://doi.org/10.1111/nmo.14703

Jodorkovsky, D., Katzka, D. A., & Gyawali, C. P. (2023). A perspective on the clinical relevance of weak or nonacid reflux. Neurogastroenterology & Motility, 35(11). Portico. https://doi.org/10.1111/nmo.14671

Montalvo, M., Nallapaneni, P., Hassan, S., Nurko, S., Pittock, S. J., & Khlevner, J. (2022). Autoimmune gastrointestinal dysmotility following SARS‐CoV‐2 infection successfully treated with intravenous immunoglobulin. Neurogastroenterology & Motility, 34(7). Portico. https://doi.org/10.1111/nmo.14314